Evaluation of Gas 6 as a Prognostic Marker in Papillary Renal Cell Carcinoma
Abstract Introduction: Growth arrest-specific protein 6 (Gas 6) is a ligand that plays a role in proliferation and migration of cells. For several tumor entities, high levels of Gas 6 are associated with poorer survival. We examined the prognostic role of Gas 6 in renal cell carcinoma (RCC), especia...
Gespeichert in:
| Veröffentlicht in: | Urologia internationalis 2023-08, Vol.107 (7), p.713-722 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 722 |
|---|---|
| container_issue | 7 |
| container_start_page | 713 |
| container_title | Urologia internationalis |
| container_volume | 107 |
| creator | Mikuteit, Marie Zschäbitz, Stefanie Stöhr, Christine Herrmann, Edwin Polifka, Iris Agaimy, Abbas Trojan, Lutz Ströbel, Philipp Becker, Frank Wülfing, Christian Barth, Peter Stöckle, Michael Staehler, Michael Stief, Christian Haferkamp, Axel Hohenfellner, Markus Duensing, Stefan Macher-Göppinger, Stephan Wullich, Bernd Noldus, Joachim Brenner, Walburgis Roos, Frederik Walter, Bernhard Otto, Wolfgang Burger, Maximilian Erlmeier, Maximillian Schrader, Andres Jan Hartmann, Arndt Erlmeier, Franziska Steffens, Sandra |
| description | Abstract
Introduction: Growth arrest-specific protein 6 (Gas 6) is a ligand that plays a role in proliferation and migration of cells. For several tumor entities, high levels of Gas 6 are associated with poorer survival. We examined the prognostic role of Gas 6 in renal cell carcinoma (RCC), especially in papillary RCC (pRCC), which is still unclear. Methods: The patients’ sample collection is a joint collaboration of the PANZAR consortium. Patients’ medical history and tumor specimens were collected from n = 240 and n = 128 patients with type 1 and 2 pRCC, respectively. Expression of Gas 6 was determined by immunohistochemistry. Results: In total, Gas 6 staining was evaluable in 180 of 240 type 1 and 110 of 128 type 2 pRCC cases. Kaplan-Meier analysis disclosed no significant difference in 5-year overall survival for all pRCC nor either subtype. Also, Gas+ and Gas– groups did not significantly differ in any tumor or patient characteristics. Conclusion: Gas 6 was not found to be an independent prognostic marker in pRCC. Future studies are warranted to determine if Gas 6 plays a role as prognostic marker or therapeutic target in pRCC. |
| doi_str_mv | 10.1159/000529898 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_karge</sourceid><recordid>TN_cdi_proquest_miscellaneous_2829425656</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2829425656</sourcerecordid><originalsourceid>FETCH-LOGICAL-c385t-e7d5c7b3b1407141415a9bac5fc4a3a46f059cc096c5ef38f587e1c5a2d1bfb3</originalsourceid><addsrcrecordid>eNpt0M9LKzEQB_AgivapB-8iAS_Pw2qySTabk0jpU6H-QPQcZtOkRrebmmyF998baS0KEpgc8uE7k0HogJJTSoU6I4SIUtWq3kADyktWEKbUJhoQwsuCUlbvoD8pvRCSsZLbaIdJxmsu5QCNR-_QLqD3ocPB4UtIuMK5AL6PYdqF1HuDbyC-2oh9h-9h7tsW4n_8YDto8dC2uUA0vgsz2ENbDtpk91f3Lnr8N3ocXhXju8vr4cW4MKwWfWHlRBjZsIZyIinPR4BqwAhnODDglSNCGUNUZYR1rHailpYaAeWENq5hu-h8GTtfNDM7MbbrI7R6Hv0sT6YDeP3zpfPPehreNSWcMqlUTvi7SojhbWFTr2c-mfwX6GxYJF3WpeKlqESV6cmSmhhSitat-1CiP7ev19vP9uj7YGv5te4MjpfgFeLUxjV4ur5dRuj5xGV1-KtadfkALmKUjw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2829425656</pqid></control><display><type>article</type><title>Evaluation of Gas 6 as a Prognostic Marker in Papillary Renal Cell Carcinoma</title><source>Karger Journals</source><source>MEDLINE</source><creator>Mikuteit, Marie ; Zschäbitz, Stefanie ; Stöhr, Christine ; Herrmann, Edwin ; Polifka, Iris ; Agaimy, Abbas ; Trojan, Lutz ; Ströbel, Philipp ; Becker, Frank ; Wülfing, Christian ; Barth, Peter ; Stöckle, Michael ; Staehler, Michael ; Stief, Christian ; Haferkamp, Axel ; Hohenfellner, Markus ; Duensing, Stefan ; Macher-Göppinger, Stephan ; Wullich, Bernd ; Noldus, Joachim ; Brenner, Walburgis ; Roos, Frederik ; Walter, Bernhard ; Otto, Wolfgang ; Burger, Maximilian ; Erlmeier, Maximillian ; Schrader, Andres Jan ; Hartmann, Arndt ; Erlmeier, Franziska ; Steffens, Sandra</creator><creatorcontrib>Mikuteit, Marie ; Zschäbitz, Stefanie ; Stöhr, Christine ; Herrmann, Edwin ; Polifka, Iris ; Agaimy, Abbas ; Trojan, Lutz ; Ströbel, Philipp ; Becker, Frank ; Wülfing, Christian ; Barth, Peter ; Stöckle, Michael ; Staehler, Michael ; Stief, Christian ; Haferkamp, Axel ; Hohenfellner, Markus ; Duensing, Stefan ; Macher-Göppinger, Stephan ; Wullich, Bernd ; Noldus, Joachim ; Brenner, Walburgis ; Roos, Frederik ; Walter, Bernhard ; Otto, Wolfgang ; Burger, Maximilian ; Erlmeier, Maximillian ; Schrader, Andres Jan ; Hartmann, Arndt ; Erlmeier, Franziska ; Steffens, Sandra ; German Network Of Kidney Cancer</creatorcontrib><description>Abstract
Introduction: Growth arrest-specific protein 6 (Gas 6) is a ligand that plays a role in proliferation and migration of cells. For several tumor entities, high levels of Gas 6 are associated with poorer survival. We examined the prognostic role of Gas 6 in renal cell carcinoma (RCC), especially in papillary RCC (pRCC), which is still unclear. Methods: The patients’ sample collection is a joint collaboration of the PANZAR consortium. Patients’ medical history and tumor specimens were collected from n = 240 and n = 128 patients with type 1 and 2 pRCC, respectively. Expression of Gas 6 was determined by immunohistochemistry. Results: In total, Gas 6 staining was evaluable in 180 of 240 type 1 and 110 of 128 type 2 pRCC cases. Kaplan-Meier analysis disclosed no significant difference in 5-year overall survival for all pRCC nor either subtype. Also, Gas+ and Gas– groups did not significantly differ in any tumor or patient characteristics. Conclusion: Gas 6 was not found to be an independent prognostic marker in pRCC. Future studies are warranted to determine if Gas 6 plays a role as prognostic marker or therapeutic target in pRCC.</description><identifier>ISSN: 0042-1138</identifier><identifier>EISSN: 1423-0399</identifier><identifier>DOI: 10.1159/000529898</identifier><identifier>PMID: 37348477</identifier><language>eng</language><publisher>Basel, Switzerland: S. Karger AG</publisher><subject>Carcinoma, Renal Cell ; Humans ; Kaplan-Meier Estimate ; Kidney Neoplasms - pathology ; Prognosis ; Research Article</subject><ispartof>Urologia internationalis, 2023-08, Vol.107 (7), p.713-722</ispartof><rights>2023 The Author(s). Published by S. Karger AG, Basel</rights><rights>2023 The Author(s). Published by S. Karger AG, Basel.</rights><rights>2023 The Author(s). Published by S. Karger AG, Basel 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c385t-e7d5c7b3b1407141415a9bac5fc4a3a46f059cc096c5ef38f587e1c5a2d1bfb3</cites><orcidid>0000-0001-5991-0146 ; 0000-0002-0445-8161 ; 0000-0001-7840-138X ; 0000-0002-1511-6212 ; 0000-0001-7501-4886 ; 0000-0002-4574-6522 ; 0000-0002-9250-354X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,2423,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37348477$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mikuteit, Marie</creatorcontrib><creatorcontrib>Zschäbitz, Stefanie</creatorcontrib><creatorcontrib>Stöhr, Christine</creatorcontrib><creatorcontrib>Herrmann, Edwin</creatorcontrib><creatorcontrib>Polifka, Iris</creatorcontrib><creatorcontrib>Agaimy, Abbas</creatorcontrib><creatorcontrib>Trojan, Lutz</creatorcontrib><creatorcontrib>Ströbel, Philipp</creatorcontrib><creatorcontrib>Becker, Frank</creatorcontrib><creatorcontrib>Wülfing, Christian</creatorcontrib><creatorcontrib>Barth, Peter</creatorcontrib><creatorcontrib>Stöckle, Michael</creatorcontrib><creatorcontrib>Staehler, Michael</creatorcontrib><creatorcontrib>Stief, Christian</creatorcontrib><creatorcontrib>Haferkamp, Axel</creatorcontrib><creatorcontrib>Hohenfellner, Markus</creatorcontrib><creatorcontrib>Duensing, Stefan</creatorcontrib><creatorcontrib>Macher-Göppinger, Stephan</creatorcontrib><creatorcontrib>Wullich, Bernd</creatorcontrib><creatorcontrib>Noldus, Joachim</creatorcontrib><creatorcontrib>Brenner, Walburgis</creatorcontrib><creatorcontrib>Roos, Frederik</creatorcontrib><creatorcontrib>Walter, Bernhard</creatorcontrib><creatorcontrib>Otto, Wolfgang</creatorcontrib><creatorcontrib>Burger, Maximilian</creatorcontrib><creatorcontrib>Erlmeier, Maximillian</creatorcontrib><creatorcontrib>Schrader, Andres Jan</creatorcontrib><creatorcontrib>Hartmann, Arndt</creatorcontrib><creatorcontrib>Erlmeier, Franziska</creatorcontrib><creatorcontrib>Steffens, Sandra</creatorcontrib><creatorcontrib>German Network Of Kidney Cancer</creatorcontrib><title>Evaluation of Gas 6 as a Prognostic Marker in Papillary Renal Cell Carcinoma</title><title>Urologia internationalis</title><addtitle>Urol Int</addtitle><description>Abstract
Introduction: Growth arrest-specific protein 6 (Gas 6) is a ligand that plays a role in proliferation and migration of cells. For several tumor entities, high levels of Gas 6 are associated with poorer survival. We examined the prognostic role of Gas 6 in renal cell carcinoma (RCC), especially in papillary RCC (pRCC), which is still unclear. Methods: The patients’ sample collection is a joint collaboration of the PANZAR consortium. Patients’ medical history and tumor specimens were collected from n = 240 and n = 128 patients with type 1 and 2 pRCC, respectively. Expression of Gas 6 was determined by immunohistochemistry. Results: In total, Gas 6 staining was evaluable in 180 of 240 type 1 and 110 of 128 type 2 pRCC cases. Kaplan-Meier analysis disclosed no significant difference in 5-year overall survival for all pRCC nor either subtype. Also, Gas+ and Gas– groups did not significantly differ in any tumor or patient characteristics. Conclusion: Gas 6 was not found to be an independent prognostic marker in pRCC. Future studies are warranted to determine if Gas 6 plays a role as prognostic marker or therapeutic target in pRCC.</description><subject>Carcinoma, Renal Cell</subject><subject>Humans</subject><subject>Kaplan-Meier Estimate</subject><subject>Kidney Neoplasms - pathology</subject><subject>Prognosis</subject><subject>Research Article</subject><issn>0042-1138</issn><issn>1423-0399</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>M--</sourceid><sourceid>EIF</sourceid><recordid>eNpt0M9LKzEQB_AgivapB-8iAS_Pw2qySTabk0jpU6H-QPQcZtOkRrebmmyF998baS0KEpgc8uE7k0HogJJTSoU6I4SIUtWq3kADyktWEKbUJhoQwsuCUlbvoD8pvRCSsZLbaIdJxmsu5QCNR-_QLqD3ocPB4UtIuMK5AL6PYdqF1HuDbyC-2oh9h-9h7tsW4n_8YDto8dC2uUA0vgsz2ENbDtpk91f3Lnr8N3ocXhXju8vr4cW4MKwWfWHlRBjZsIZyIinPR4BqwAhnODDglSNCGUNUZYR1rHailpYaAeWENq5hu-h8GTtfNDM7MbbrI7R6Hv0sT6YDeP3zpfPPehreNSWcMqlUTvi7SojhbWFTr2c-mfwX6GxYJF3WpeKlqESV6cmSmhhSitat-1CiP7ev19vP9uj7YGv5te4MjpfgFeLUxjV4ur5dRuj5xGV1-KtadfkALmKUjw</recordid><startdate>20230801</startdate><enddate>20230801</enddate><creator>Mikuteit, Marie</creator><creator>Zschäbitz, Stefanie</creator><creator>Stöhr, Christine</creator><creator>Herrmann, Edwin</creator><creator>Polifka, Iris</creator><creator>Agaimy, Abbas</creator><creator>Trojan, Lutz</creator><creator>Ströbel, Philipp</creator><creator>Becker, Frank</creator><creator>Wülfing, Christian</creator><creator>Barth, Peter</creator><creator>Stöckle, Michael</creator><creator>Staehler, Michael</creator><creator>Stief, Christian</creator><creator>Haferkamp, Axel</creator><creator>Hohenfellner, Markus</creator><creator>Duensing, Stefan</creator><creator>Macher-Göppinger, Stephan</creator><creator>Wullich, Bernd</creator><creator>Noldus, Joachim</creator><creator>Brenner, Walburgis</creator><creator>Roos, Frederik</creator><creator>Walter, Bernhard</creator><creator>Otto, Wolfgang</creator><creator>Burger, Maximilian</creator><creator>Erlmeier, Maximillian</creator><creator>Schrader, Andres Jan</creator><creator>Hartmann, Arndt</creator><creator>Erlmeier, Franziska</creator><creator>Steffens, Sandra</creator><general>S. Karger AG</general><scope>M--</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-5991-0146</orcidid><orcidid>https://orcid.org/0000-0002-0445-8161</orcidid><orcidid>https://orcid.org/0000-0001-7840-138X</orcidid><orcidid>https://orcid.org/0000-0002-1511-6212</orcidid><orcidid>https://orcid.org/0000-0001-7501-4886</orcidid><orcidid>https://orcid.org/0000-0002-4574-6522</orcidid><orcidid>https://orcid.org/0000-0002-9250-354X</orcidid></search><sort><creationdate>20230801</creationdate><title>Evaluation of Gas 6 as a Prognostic Marker in Papillary Renal Cell Carcinoma</title><author>Mikuteit, Marie ; Zschäbitz, Stefanie ; Stöhr, Christine ; Herrmann, Edwin ; Polifka, Iris ; Agaimy, Abbas ; Trojan, Lutz ; Ströbel, Philipp ; Becker, Frank ; Wülfing, Christian ; Barth, Peter ; Stöckle, Michael ; Staehler, Michael ; Stief, Christian ; Haferkamp, Axel ; Hohenfellner, Markus ; Duensing, Stefan ; Macher-Göppinger, Stephan ; Wullich, Bernd ; Noldus, Joachim ; Brenner, Walburgis ; Roos, Frederik ; Walter, Bernhard ; Otto, Wolfgang ; Burger, Maximilian ; Erlmeier, Maximillian ; Schrader, Andres Jan ; Hartmann, Arndt ; Erlmeier, Franziska ; Steffens, Sandra</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c385t-e7d5c7b3b1407141415a9bac5fc4a3a46f059cc096c5ef38f587e1c5a2d1bfb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Carcinoma, Renal Cell</topic><topic>Humans</topic><topic>Kaplan-Meier Estimate</topic><topic>Kidney Neoplasms - pathology</topic><topic>Prognosis</topic><topic>Research Article</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mikuteit, Marie</creatorcontrib><creatorcontrib>Zschäbitz, Stefanie</creatorcontrib><creatorcontrib>Stöhr, Christine</creatorcontrib><creatorcontrib>Herrmann, Edwin</creatorcontrib><creatorcontrib>Polifka, Iris</creatorcontrib><creatorcontrib>Agaimy, Abbas</creatorcontrib><creatorcontrib>Trojan, Lutz</creatorcontrib><creatorcontrib>Ströbel, Philipp</creatorcontrib><creatorcontrib>Becker, Frank</creatorcontrib><creatorcontrib>Wülfing, Christian</creatorcontrib><creatorcontrib>Barth, Peter</creatorcontrib><creatorcontrib>Stöckle, Michael</creatorcontrib><creatorcontrib>Staehler, Michael</creatorcontrib><creatorcontrib>Stief, Christian</creatorcontrib><creatorcontrib>Haferkamp, Axel</creatorcontrib><creatorcontrib>Hohenfellner, Markus</creatorcontrib><creatorcontrib>Duensing, Stefan</creatorcontrib><creatorcontrib>Macher-Göppinger, Stephan</creatorcontrib><creatorcontrib>Wullich, Bernd</creatorcontrib><creatorcontrib>Noldus, Joachim</creatorcontrib><creatorcontrib>Brenner, Walburgis</creatorcontrib><creatorcontrib>Roos, Frederik</creatorcontrib><creatorcontrib>Walter, Bernhard</creatorcontrib><creatorcontrib>Otto, Wolfgang</creatorcontrib><creatorcontrib>Burger, Maximilian</creatorcontrib><creatorcontrib>Erlmeier, Maximillian</creatorcontrib><creatorcontrib>Schrader, Andres Jan</creatorcontrib><creatorcontrib>Hartmann, Arndt</creatorcontrib><creatorcontrib>Erlmeier, Franziska</creatorcontrib><creatorcontrib>Steffens, Sandra</creatorcontrib><creatorcontrib>German Network Of Kidney Cancer</creatorcontrib><collection>Karger Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Urologia internationalis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mikuteit, Marie</au><au>Zschäbitz, Stefanie</au><au>Stöhr, Christine</au><au>Herrmann, Edwin</au><au>Polifka, Iris</au><au>Agaimy, Abbas</au><au>Trojan, Lutz</au><au>Ströbel, Philipp</au><au>Becker, Frank</au><au>Wülfing, Christian</au><au>Barth, Peter</au><au>Stöckle, Michael</au><au>Staehler, Michael</au><au>Stief, Christian</au><au>Haferkamp, Axel</au><au>Hohenfellner, Markus</au><au>Duensing, Stefan</au><au>Macher-Göppinger, Stephan</au><au>Wullich, Bernd</au><au>Noldus, Joachim</au><au>Brenner, Walburgis</au><au>Roos, Frederik</au><au>Walter, Bernhard</au><au>Otto, Wolfgang</au><au>Burger, Maximilian</au><au>Erlmeier, Maximillian</au><au>Schrader, Andres Jan</au><au>Hartmann, Arndt</au><au>Erlmeier, Franziska</au><au>Steffens, Sandra</au><aucorp>German Network Of Kidney Cancer</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evaluation of Gas 6 as a Prognostic Marker in Papillary Renal Cell Carcinoma</atitle><jtitle>Urologia internationalis</jtitle><addtitle>Urol Int</addtitle><date>2023-08-01</date><risdate>2023</risdate><volume>107</volume><issue>7</issue><spage>713</spage><epage>722</epage><pages>713-722</pages><issn>0042-1138</issn><eissn>1423-0399</eissn><abstract>Abstract
Introduction: Growth arrest-specific protein 6 (Gas 6) is a ligand that plays a role in proliferation and migration of cells. For several tumor entities, high levels of Gas 6 are associated with poorer survival. We examined the prognostic role of Gas 6 in renal cell carcinoma (RCC), especially in papillary RCC (pRCC), which is still unclear. Methods: The patients’ sample collection is a joint collaboration of the PANZAR consortium. Patients’ medical history and tumor specimens were collected from n = 240 and n = 128 patients with type 1 and 2 pRCC, respectively. Expression of Gas 6 was determined by immunohistochemistry. Results: In total, Gas 6 staining was evaluable in 180 of 240 type 1 and 110 of 128 type 2 pRCC cases. Kaplan-Meier analysis disclosed no significant difference in 5-year overall survival for all pRCC nor either subtype. Also, Gas+ and Gas– groups did not significantly differ in any tumor or patient characteristics. Conclusion: Gas 6 was not found to be an independent prognostic marker in pRCC. Future studies are warranted to determine if Gas 6 plays a role as prognostic marker or therapeutic target in pRCC.</abstract><cop>Basel, Switzerland</cop><pub>S. Karger AG</pub><pmid>37348477</pmid><doi>10.1159/000529898</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0001-5991-0146</orcidid><orcidid>https://orcid.org/0000-0002-0445-8161</orcidid><orcidid>https://orcid.org/0000-0001-7840-138X</orcidid><orcidid>https://orcid.org/0000-0002-1511-6212</orcidid><orcidid>https://orcid.org/0000-0001-7501-4886</orcidid><orcidid>https://orcid.org/0000-0002-4574-6522</orcidid><orcidid>https://orcid.org/0000-0002-9250-354X</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0042-1138 |
| ispartof | Urologia internationalis, 2023-08, Vol.107 (7), p.713-722 |
| issn | 0042-1138 1423-0399 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2829425656 |
| source | Karger Journals; MEDLINE |
| subjects | Carcinoma, Renal Cell Humans Kaplan-Meier Estimate Kidney Neoplasms - pathology Prognosis Research Article |
| title | Evaluation of Gas 6 as a Prognostic Marker in Papillary Renal Cell Carcinoma |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T11%3A02%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_karge&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evaluation%20of%20Gas%206%20as%20a%20Prognostic%20Marker%20in%20Papillary%20Renal%20Cell%20Carcinoma&rft.jtitle=Urologia%20internationalis&rft.au=Mikuteit,%20Marie&rft.aucorp=German%20Network%20Of%20Kidney%20Cancer&rft.date=2023-08-01&rft.volume=107&rft.issue=7&rft.spage=713&rft.epage=722&rft.pages=713-722&rft.issn=0042-1138&rft.eissn=1423-0399&rft_id=info:doi/10.1159/000529898&rft_dat=%3Cproquest_karge%3E2829425656%3C/proquest_karge%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2829425656&rft_id=info:pmid/37348477&rfr_iscdi=true |